TRIM38 and colorectal carcinoma: Then, by establishing AOM/DSS‐induced CRC models (Figure 2K), we observed that AAV9‐TRIM38 effectively inhibited the progression of CRC, as indicated by a reduction in both tumor number and volume (Figure 2L–N).